• PNS46 Exploration of the Weight-Loss Management Service at Community Pharmacy in Malaysia

    Sep 1, 2020, 00:00

  • PDG3 Comparison of Pharmacoeconomic Evaluation Guidelines in Korea, JAPAN and China

    Sep 1, 2020, 00:00

  • PMH3 Desogestrel: Does IT Cause Severe Psychiatric Disorders, a Retrospective Analysis of FDA Adverse Event Reporting System and Eudravigilance

    Sep 1, 2020, 00:00

  • PCN21 Disease Burden of Multiple Myeloma UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PNS33 Developing and Adopting Regulatory Scien Experiences of Drug Regulatory Authorities in China, United States, European Union, and JAPAN

    Sep 1, 2020, 00:00

  • PCN69 The IMPACT of Patient Access Schemes for Innovative Cancer Therapies in FOUR Asian Countries: A MIXED-Method Review

    Sep 1, 2020, 00:00

  • PNS11 Changes in the Latest Chinese Guidelines for Pharmacoeconomic Evaluations

    Sep 1, 2020, 00:00

  • PDB13 The Cost-Effectiveness of Diabetes Prevention Programmes in Bangladesh

    Sep 1, 2020, 00:00

  • PND16 Quantifying the Burden of Migraine in JAPAN: A Propensity-Score Matched Analysis of a Population-Based Survey

    Sep 1, 2020, 00:00

  • Making Connections and Measuring Performance: Bibliometric Analysis of Multi-Attribute, Preference-Based Health-Related Quality of Life Research in South Africa

    Sep 1, 2020, 00:00

  • Elevated Costs and Healthcare Resource Utilization in Patients With Type 2 Diabetes and Established Cardiovascular Disease in Israel

    Sep 1, 2020, 00:00

  • PND15 The Health and Productivity Burden of Migraines in Australia

    Sep 1, 2020, 00:00

  • PCN55 A Systematic Review and Narrative Synthesis of Health Economic Evaluations of Hepatocellular Carcinoma (HCC) Screening Strategies

    Sep 1, 2020, 00:00

  • PCN73 Is Time to Access Novel Cancer Therapies in Asia Accelerating? A Preliminary Investigation

    Sep 1, 2020, 00:00

  • PNS63 A Cross-Sectional Study About Medications Wastage In Saudi Arabia

    Sep 1, 2020, 00:00

  • Editorial Board

    Sep 1, 2020, 00:00

  • PIN41 Economic Burden of 2009 Pandemic H1N1 Influenza in Mainland China: A Systematic Review and Modelling Study

    Sep 1, 2020, 00:00

  • PDG22 Comparison of Healthcare Systems and Opportunities for Innovative Drugs across India, Vietnam, and Indonesia

    Sep 1, 2020, 00:00

  • PMH9 Comparison of Approved Doses of Lemborexant for Insomnia in Placebo-Controlled Trials: A Systematic Review and Network Meta-Analysis

    Sep 1, 2020, 00:00

  • PDB30 Digital Medication Health Service Platforms of Pharmaceutical Companies for Type 2 Diabetes Mellitus (T2DM) Patients: A Content Analysis of Application

    Sep 1, 2020, 00:00

  • PDB23 Efficacy and Safety of Teprotumumab in the Treatment of Thyroid Eye Disorder: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PCN72 APAC Overview of the Accelerated Approval Pathways: Applications in LUNG Cancer

    Sep 1, 2020, 00:00

  • PCV16 Increasing Burden of Cardiovascular Disease (CVD), the Associated Risk Factors and Drug Utilization Among Smokers in the US: A Study Based on Nhanes from 2005 to 2016

    Sep 1, 2020, 00:00

  • PCN64 Frequency of ORAL Mucositis in Male Patients Receiving Cancer Therapy

    Sep 1, 2020, 00:00

  • PDB5 Assesment the Quality of Life in Children with Type 1 Diabetes

    Sep 1, 2020, 00:00

  • PDG9 Cost Effectiveness Analysis of Blonanserin Versus Olanzapine As First-LINE Treatment for Patients with Schizophrenia in China

    Sep 1, 2020, 00:00

  • PND4 Exploratory Cost-Effectiveness Analysis of Thread Embedding Acupuncture Plus Usual Care Versus Usual Care Alone for Treating Sequelae in Bell's Palsy Patients: An Economic Evaluation Alongside a Clinical Trial

    Sep 1, 2020, 00:00

  • PNS39 History, Present, and Future of DRG-Based Payment Systems in EAST ASIA - Experience from South Korea, JAPAN, and Taiwan and the Introduction in China

    Sep 1, 2020, 00:00

  • List of Reviewers

    Sep 1, 2020, 00:00

  • PCN33 Cost-Effectiveness of Molecular Screening to Identify Lynch Syndrome in Iranian Patients with Colorectal Cancer

    Sep 1, 2020, 00:00

  • PMH10 Depression Severity Is Associated with Physical PAIN Severity across Countries

    Sep 1, 2020, 00:00

  • PDG4 Cost-Utilities Analysis of First LINE Treatments on Advanced STAGE EGFR Positive in NON-SMALL CELL LUNG Cancer Patients in Taiwan

    Sep 1, 2020, 00:00

  • PCN83 Real-World Prescription Patterns of HER2+/HR- Metastatic Breast Cancer Patients after Ado-Trastuzumab Emtansine Approval: A Retrospective Cohort Study Using Electronic Health Record DATA with Cancer Registries

    Sep 1, 2020, 00:00

  • PSS5 Disease Burden of Rvo-ME in China——a Societal VALUE Perspective

    Sep 1, 2020, 00:00

  • PCN84 Comparison of Treatment Among Peripheral T-CELL Lymphoma and Cutaneous T-CELL Lymphoma in China and United States: Results of Primary Market Research Survey of Oncologists

    Sep 1, 2020, 00:00

  • PCV29 Iqvia Hospital Information System DATA Secondary Use for Outcome Identification to Assess the Validity of Definitions

    Sep 1, 2020, 00:00

  • PCN51 Disease Burden of Mantle CELL Lymphoma UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PDB16 Identifying Prevalence and Risk Factors of Poor Glycemic Control Among Diabetic Patients in a Central RURAL Province of Saudi Arabia

    Sep 1, 2020, 00:00

  • PNS3 Managed Entry Agreements: The European Experience and the Potential in JAPAN

    Sep 1, 2020, 00:00

  • PMU2 Will Vaccinating an Aging Population Lead to Good Return on Investment?

    Sep 1, 2020, 00:00

  • PCV28 The EQ-5D-5L Is More Discriminative Than The EQ-5D-3L In Patients With Cardiovascular Diseases: A Multi-Ethnic Asian Study

    Sep 1, 2020, 00:00

  • PRS10 Impact of Tobacco Smoking before Pregnancy on Quality of Life of Pregnant Women: A National Cross-Sectional Study

    Sep 1, 2020, 00:00

  • PMH8 A DEEP Learning Approach for Predicting Onset of Depressive Disorder Using Health Insurance Claims DATA

    Sep 1, 2020, 00:00

  • PDG10 An Economic Evaluation of Tofacitinib for the Treatment of Moderate to Severe Rheumatoid Arthritis in Singapore

    Sep 1, 2020, 00:00

  • PDB28 A Real-World Effectiveness of Udca Added to Oha on Glycemic Control in Type 2 Diabetes Patients with LIVER Disease

    Sep 1, 2020, 00:00

  • PRO11 Policy Initiatives to Facilitate the Patient Access to Orphan Drugs in China

    Sep 1, 2020, 00:00

  • PCN78 Cost Comparison of Administering ORAL Compared to Intravenous paclitaxel for Patients with Advanced Gastric Cancer in South Korea: A MICRO-Costing Study

    Sep 1, 2020, 00:00

  • PIH12 COMPARISON OF THE POST-MARKET UTILIZATION PATTERNS OF ALZHEIMER'S DISEASE TREATMENTS BETWEEN SOUTH KOREA AND AUSTRALIA: TIME TO CONSIDER REASSESSMENT OF COST-EFFECTIVENESS

    Sep 1, 2020, 00:00

  • Knowledge and Attitude of Physicians Towards the Cost of Commonly Prescribed Medicines: A Case Study in Three Nigerian Healthcare Facilities

    Sep 1, 2020, 00:00

  • PDB29 Diagnostic and Prognostic VALUE of Galectin-3 and GDF-15 in Diabetic Nephropathy Patients

    Sep 1, 2020, 00:00

  • PIN14 Health and Economic IMPACT of 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Adults 65 YEARS and Older in Korea

    Sep 1, 2020, 00:00

  • PNS2 Voice Technology - an Opportunity to Broaden Participation in Patient Reported Outcomes Research

    Sep 1, 2020, 00:00

  • PDG19 Status of Published Pharmacoeconomic Evidence on Monoclonal Antibodies Reimbursed in China

    Sep 1, 2020, 00:00

  • The Cost-Effectiveness of Abdominal Aortic Aneurysm Screening in Estonia

    Sep 1, 2020, 00:00

  • PCV17 Systematic Literature Review of Cardiovascular Risk Factor Management in 11 Asian Markets

    Sep 1, 2020, 00:00

  • PCN61 Frequency of Myalgia in Patients with Gynecological Cancer

    Sep 1, 2020, 00:00

  • PCN22 Cost-Effectiveness of Pembrolizumab PLUS Axitinib Versus Nivolumab PLUS Ipilimumab As First-LINE Treatment of Advanced Renal CELL Carcinoma

    Sep 1, 2020, 00:00

  • PCV27 Assessment of Health Related Quality of Life Among Adherent and NON-Adherent Medication Group of Coronary Artery Disease Patients

    Sep 1, 2020, 00:00

  • PCN81 The Role of Different Specialties in the Management of NON-SMALL CELL LUNG Cancer: Insights from a Real-World Study

    Sep 1, 2020, 00:00

  • PND22 Application of Therapeutic Plasma Exchange in a Single Public Hospital

    Sep 1, 2020, 00:00

  • PBI5 Future Trends on the Biosimilar Uptake in China, JAPAN, the US, the EU4 and the UK

    Sep 1, 2020, 00:00

  • PRO10 Income LEVEL Shift of RARE Disease Patients in South Korea

    Sep 1, 2020, 00:00

  • PSU11 Trends in the Adoption of Minimally Invasive Partial Nephrectomy in South Korea

    Sep 1, 2020, 00:00

  • PND2 A Meta-Analysis of Efficacy and Safety of Vesicular Monoamine Transporter Type 2 Inhibitors for Treatment of Huntington Chorea

    Sep 1, 2020, 00:00

  • PND12 Vagus Nerve Stimulation Versus ANTI-Epileptic Drug in Chinese Patients with Drug-Resistant Epilepsy: A Cost–Effectiveness Analysis

    Sep 1, 2020, 00:00

  • PNS65 Comparison of Quality of Life and Burden of Lower Back PAIN Among Patients with and without a Diagnosis in Korea, Taiwan, JAPAN and USA

    Sep 1, 2020, 00:00

  • PBI7 Comparison of Biosimilar Policies between Key Countries in ASIA, EU and USA

    Sep 1, 2020, 00:00

  • PDG14 Evaluating Accessibility of Essential Medicines in Indonesia: A Survey on Availability and Price in Public and Private Health Sectors

    Sep 1, 2020, 00:00

  • PCN5 Real-World Incidence and Management of Adverse Events (AE) in Patients with NON-Metastatic Castrate-Resistant Prostate Cancer Receiving Apalutamide or Enzalutamide

    Sep 1, 2020, 00:00

  • PDB20 Clinical Outcomes Among Patients with Hyperkalemia in China: A Population-Based Retrospective Study

    Sep 1, 2020, 00:00

  • PMU13 Defining the ROLL out Strategy for UHC Benefits: Philhealth's Benefit Development PLAN

    Sep 1, 2020, 00:00

  • PMH1 MODEL Based Pharmacoeconomic Evaluation of Medication for Depression Disorder: A Systematic Review

    Sep 1, 2020, 00:00

  • PMS1 Economic Outcomes of Ankylosing Spondylitis Patients Initiating Biologic Therapy in Taiwan - a Population-Based Analysis

    Sep 1, 2020, 00:00

  • PCV4 Review On:-Cardiovascular Risk Reduction With Icosapent Ethyl For Hypertriglyceridemia

    Sep 1, 2020, 00:00

  • PMH13 Children with Computer GAME Addiction Benefit from Visuospatial Training

    Sep 1, 2020, 00:00

  • PCN50 Disease Burden of Chronic Myeloid Leukemia UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PAM1 Efficacy and Safety of Prebiotics, Probiotics and Synbiotics for Treatment or Prevention of Asthma: A Systematic Review and Network Meta-Analysis

    Sep 1, 2020, 00:00

  • PCN107 Real World Chart Review of Treatment Patterns and Health Resource Utilization in Patients with Hepatocellular Carcinoma (HCC) Following Failure of Sorafenib in Korea

    Sep 1, 2020, 00:00

  • PRS16 Development of an Accurate Operational Definition for Asthma Using Logistic Regression MODEL

    Sep 1, 2020, 00:00

  • PSU1 Real-World Cost-Effectiveness Analysis of Minimal Invasive PLATE Osteosynthesis (MIPO) Versus Conventional OPEN Reduction Internal Fixation of Proximal Humeral Fracture (PHF)

    Sep 1, 2020, 00:00

  • PSU9 The Cost Analysis of Patients Undergoing TOTAL Knee Arthroplasty in China

    Sep 1, 2020, 00:00

  • PNS55 The Effect of Pharmaceutical Policy on Demand for Branded Medicines: A Discrete Choice Experiment from Australia

    Sep 1, 2020, 00:00

  • PCN18 A Budget IMPACT Analysis of Fixed Dose Combination of Netupitant and Palonosetron (NEPA) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Malaysia

    Sep 1, 2020, 00:00

  • PRO6 Epidemiology and Treatment Patterns of Hemophilia a in Taiwan from 2013 to 2017

    Sep 1, 2020, 00:00

  • PIN54 Association of Maternal Hbsag and Hbeag Serostatus and Congenital Abnormalities Following Assisted Reproduction: A Population-Based Study

    Sep 1, 2020, 00:00

  • PCV18 Risk Prediction Models for in-Hospital Mortality in ACUTE Aortic Dissection: A Systematic Review

    Sep 1, 2020, 00:00

  • PNS52 Valuating Pharmaceutical Innovations Beyond Qalys: A Comprehensive Analysis of VALUE-Based Pricing Models

    Sep 1, 2020, 00:00

  • PDB17 Time to Onset Analysis of Ipilimumab Associated Hypophysitis Using DATA from FDA Adverse Event Reporting System (FAERS) Database

    Sep 1, 2020, 00:00

  • PDB25 Long-Term Drug Survival and Low Remission Rates in Dyslipidemia Patients Having Drug Safety Concerned and Safety Literacy

    Sep 1, 2020, 00:00

  • PBI2 Economic Evaluation of GENE Therapies: IMPACT of Alternative Payment Models on Uncertainty Around the Icer

    Sep 1, 2020, 00:00

  • PIH11 Falls Risk Increasing Drugs in the Elderly: Population Based Study Using Korean National Health Insurance Claims Database

    Sep 1, 2020, 00:00

  • PIN51 Out-of-Pocket Healthcare Expenditure in Various Household Income Groups Among Patients with Hepatitis C Disease Stages: Findings from a Tertiary Care Centre in Malaysia

    Sep 1, 2020, 00:00

  • PSU6 A Patient-LEVEL Simulation for Economic Evaluation of Vascular Service Reconfiguration in England

    Sep 1, 2020, 00:00

  • PCN88 HTA Evaluations of Oncology Drugs in APAC - Comparison of Trends and Drivers of Success in 5 Countries

    Sep 1, 2020, 00:00

  • PUK4 Cost-Effectiveness of Robotic-Assisted Partial Nephrectomy

    Sep 1, 2020, 00:00

  • PMS5 Incidence and Risk Factors for Subsequent Osteoporotic Fracture: A Nationwide Cohort Study in South Korea

    Sep 1, 2020, 00:00

  • PMD14 Economic Analysis to Evaluate IMPACT of Prostheses Choice in Primary TOTAL Knee Arthroplasty

    Sep 1, 2020, 00:00

  • PIH14 Perception of Seriousness, Knowledge, and Willingness to Pay for Cervical Cancer Screening Among Women in Yogyakarta Province, Indonesia

    Sep 1, 2020, 00:00

  • PCN101 Healthcare Resource Utilization, Costs, and Clinical Outcomes in Patients with Triple-Negative Breast Cancer in Northern Thailand: A Real World Evidence Using Electronic Health Records

    Sep 1, 2020, 00:00

  • PCN43 Disease Burden of NON-SMALL CELL Cancer UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PMS2 Disease Burden of Subsequent Fracture in Osteoporosis Patients in South Korea

    Sep 1, 2020, 00:00

  • PMH15 Children with Deficit in Executive Abilities Have a Risk for Emerging Weakness in Grammar Understanding

    Sep 1, 2020, 00:00

  • PND7 Cost-Effectiveness of Cladribine Tablets in the Treatment of Relapsing-Remitting Multiple Sclerosis with High Disease Activity in Kazakhstan

    Sep 1, 2020, 00:00

  • PMU17 Health Technology Assessment for Procedures: The Evaluation of Innovation in JAPAN

    Sep 1, 2020, 00:00

  • PCN74 Analyze Oncology Drug Price Change in the Chinese Market through National Reimbursement Drug LIST Negotiation

    Sep 1, 2020, 00:00

  • PNS30 IMPACT of Cigarette Tax on Youth Smoking in Taiwan

    Sep 1, 2020, 00:00

  • PMS16 Longitudinal Analyses of Health-Related Quality of Life and Daily Activities Function Among HIP Fracture Population: A Real-World Prospective Cohort Study

    Sep 1, 2020, 00:00

  • PDG27 The Complexity and Cost of Drug Regimens for Hypertensive Patients in China

    Sep 1, 2020, 00:00

  • PIN24 Disease Burden of Progressive Chronic Hepatitis C in China

    Sep 1, 2020, 00:00

  • The Coronavirus Disease 2019 (COVID-19) Pandemic in Africa: What Can We Expect? [Editor's Choice]

    Sep 1, 2020, 00:00

  • Copyright/Subscription

    Jun 3, 2020, 09:04

  • Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin Regimen for Patients Infected With Chronic Hepatitis C Virus Genotype 1 in Malaysia

    May 1, 2020, 00:00

  • Addressing the Cost Data Gap for Universal Healthcare Coverage in India: A Call to Action

    May 1, 2020, 00:00

  • The Impact of the Pharmaceutical Care Management Model of Hepatitis C Medications on the Cost at Health Insurance Level

    May 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Xpert MTB/RIF for Multi-Outcomes of Patients With Presumptive Pulmonary Tuberculosis in Thailand [Editor's Choice]

    May 1, 2020, 00:00

  • Power of 1 Malaysian Ringgit: A Low-Cost Prescription Cost-Sharing Model in Malaysia

    May 1, 2020, 00:00

  • Assessing the Low Influenza Vaccination Coverage Rate Among Healthcare Personnel in India: A Review of Obstacles, Beliefs, and Strategies

    May 1, 2020, 00:00

  • Cost-Utility Analysis of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis for Thai Patients With End-Stage Renal Disease

    May 1, 2020, 00:00

  • A Systematic Review of Equity in Healthcare Financing in Low- and Middle-Income Countries

    May 1, 2020, 00:00

  • Kidney Disease–Specific Scores and Health Utility of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Patients and Their Caregivers

    May 1, 2020, 00:00

  • Drug Selection for Formulary Inclusion: An Exploratory Case Study of Oncology Medicines in Jordan

    May 1, 2020, 00:00

  • The Structure and Parameterization of the Breast Cancer Transition Model Among Chinese Women

    May 1, 2020, 00:00

  • The Factors Associated With Direct Medical Costs in Patients With Gastric Cancer: Quantile Regression Approach Compared With Gamma Regression

    May 1, 2020, 00:00

  • Budget Impact Analysis of Extended-Release Phenytoin Capsules Compared With Immediate-Release Phenytoin Capsules for Patients With Epilepsy in Thailand

    May 1, 2020, 00:00

  • Estimation of Quality-Adjusted Life Expectancy of Patients With Oral Cancer: Integration of Lifetime Survival With Repeated Quality-of-Life Measurements

    May 1, 2020, 00:00

  • Applying a Constrained Optimization Portfolio Model to Aid Prioritization of Public Health Interventions in Malaysia

    May 1, 2020, 00:00

  • Experience of a Performance-Based Risk-Sharing Arrangement for the Treatment of Rheumatoid Arthritis With Certolizumab Pegol

    May 1, 2020, 00:00

  • Association of Socioeconomic Status With Childhood Anemia Among Infant, Toddler, and Preschool Children in Bangladesh

    May 1, 2020, 00:00

  • Table of Contents

    May 1, 2020, 00:00

  • Survey on Willingness to Pay for Life-Saving Treatment, Functional Recovery, and Cosmesis in a Neuroscience Outpatient Clinic Setting in Singapore [Editor's Choice]

    May 1, 2020, 00:00

  • The Development of Health Technology Assessment in Asia: Current Status and Future Trends [Editor's Choice]

    May 1, 2020, 00:00

  • Cross-Cultural Adaptation and Psychometric Analysis of the Persian Version of the ICEpop CAPability Measure for Adults Capability Measure in the Iranian General Population

    May 1, 2020, 00:00

  • Population Aging, Technological Innovation, and the Growth of Health Expenditure: Evidence From Patients With Type 2 Diabetes in Taiwan

    May 1, 2020, 00:00

  • Cost-Effectiveness of Transcatheter Aortic Valve Implantation Using a Balloon-Expandable Valve in Japan: Experience From the Japanese Pilot Health Technology Assessment

    May 1, 2020, 00:00

  • Use of Reimbursed Psychology Videoconference Services in Australia: An Investigation Using Administrative Data

    May 1, 2020, 00:00

  • Relationships Between Pharmaceutical Therapy–Related Quality of Life and Health Utility Scores in Thai Patients With Chronic Diseases

    May 1, 2020, 00:00

  • Economic Evaluation of Breast Cancer Early Detection Strategies in Asia: A Systematic Review [Editor's Choice]

    May 1, 2020, 00:00

  • Tackling the 3 Big Challenges Confronting Health Technology Assessment Development in Asia: A Commentary

    May 1, 2020, 00:00

  • Complicated Issues of Medical Examination: A Case Study of the Irkutsk Region

    May 1, 2020, 00:00

  • Causes of Under-5 Mortality Among Brazil, the Russian Federation, India, China, and South Africa Nations: A Comparative Study

    May 1, 2020, 00:00

  • The Burden of Hypoglycemia in Patients With Insulin-Treated Diabetes Mellitus in China: Analysis of Electronic Medical Records From 4 Tertiary Hospitals

    May 1, 2020, 00:00

  • From Evidence to Policy: Economic Evaluations of Healthcare in Malaysia: A Systematic Review

    May 1, 2020, 00:00

  • Editorial Board

    May 1, 2020, 00:00

  • Inappropriate Rate of Admission and Hospitalization in the Iranian Hospitals: A Systematic Review and Meta-Analysis

    May 1, 2020, 00:00

  • Translation, Cultural Adaptation, and Validation of Short-Form 6D on the General Population in Indonesia

    May 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Prostate-Specific Antigen Screening Among Chinese Men

    May 1, 2020, 00:00

  • The Economic Burden of Candidemia and Invasive Candidiasis: A Systematic Review

    May 1, 2020, 00:00

  • Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand

    May 1, 2020, 00:00

  • Long Term Cost-Effectiveness of a Systolic Blood Pressure Goal of <120 mmHg in Hypertensive Patients Without Diabetes Mellitus

    May 1, 2020, 00:00

  • The Impact of Pharmaceutical Policies on Medicine Procurement Pricing in Indonesia Under the Implementation of Indonesia’s Social Health Insurance System [Editor's Choice]

    May 1, 2020, 00:00

  • Comparative Analysis of Prescription Drug Prices in South Asian Association for Regional Cooperation Countries

    May 1, 2020, 00:00

  • Determining the Cost and Length of Stay at Intensive Care Units and the Factors Influencing Them in a Teaching Hospital in Malaysia

    May 1, 2020, 00:00

  • Copyright/Subscription

    Dec 16, 2019, 08:54

  • Budgetary Impact of Oral Rehabilitation With Complete Dentures: An Economical Evaluation From São Paulo State, Brazil

    Dec 1, 2019, 00:00

  • In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of Proton Versus Photon Therapy in Pediatric Medulloblastoma Treatment: A Patient Volume–Based Analysis

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Psoriatic Arthritis: An Argentinean Perspective

    Dec 1, 2019, 00:00

  • Determining the Operating Costs of a Medical Surveillance Program for Copper Miners Exposed to High Altitude–Induced Chronic Intermittent Hypoxia in Chile Using a Combination of Microcosting and Time-Driven Activity-Based Costing

    Dec 1, 2019, 00:00

  • Editorial Board

    Dec 1, 2019, 00:00

  • Response to Letter to the Editor

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of a Technology-Enhanced Diabetes Care Management Program in Mexico

    Dec 1, 2019, 00:00

  • Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System Perspective

    Dec 1, 2019, 00:00

  • The Brazilian Portuguese Version of the DISCERN Instrument: Translation Procedures and Psychometric Properties

    Dec 1, 2019, 00:00

  • Burden of Disease Attributable to Obesity and Overweight in Colombia

    Dec 1, 2019, 00:00

  • The Impact of Price Negotiations on Public Procurement Prices and Access to 8 Innovative Cancer Medicines in a Middle-Income Country: The Case of Mexico [Editor's Choice]

    Dec 1, 2019, 00:00

  • Inflammatory Bowel Disease in Latin America: A Systematic Review

    Dec 1, 2019, 00:00

  • In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments

    Dec 1, 2019, 00:00

  • The Price of Substitute Technologies

    Dec 1, 2019, 00:00

  • Economic Cost of Severe Acute Respiratory Infection Associated to Influenza in Colombian Children: A Single Setting Analysis

    Dec 1, 2019, 00:00

  • Cost of Patients With Hemophilia A and High-Titer Inhibitors in Colombia

    Dec 1, 2019, 00:00

  • A Comparison of UK and Brazilian SF-6D Preference Weights When Applied to a Brazilian Urban Population [Editor's Choice]

    Dec 1, 2019, 00:00

  • The Public Health Benefits and Economic Value of Routine Yellow Fever Vaccination in Colombia [Editor's Choice]

    Dec 1, 2019, 00:00

  • Custo-utilidade de terapias-alvo comparadas à dacarbazina para o tratamento de primeira linha do melanoma avançado não-cirúrgico e metastático no Sistema Único de Saúde do Brazil

    Dec 1, 2019, 00:00

  • Cost-Effectiveness of Bariatric Surgery Compared With Nonsurgical Treatment in People With Obesity and Comorbidity in Colombia

    Dec 1, 2019, 00:00

  • Agnet y Judicialization en Salud en Argentina

    Dec 1, 2019, 00:00

  • Resource Utilization and Costs Associated With Percutaneous Coronary Intervention When Treating Patients With Acute Coronary Syndrome in the Mexican National Institute of Cardiology “Ignacio Chávez”

    Dec 1, 2019, 00:00

  • Prevalence of Symptoms and Symptom Clusters of Patients on Dialysis in Uruguay

    Dec 1, 2019, 00:00

  • Acuerdos de Riesgo Compartido: Lecciones Para su Diseño e Implementación a la Luz de la Experiencia Internacional

    Dec 1, 2019, 00:00

  • Challenges in the Regulation of High-Cost Treatments: An Overview From Brazil [Editor's Choice]

    Dec 1, 2019, 00:00

  • Costo de la intoxicación por Paraquat en Colombia

    Dec 1, 2019, 00:00

  • Table of Contents

    Dec 1, 2019, 00:00

  • Beneficio económico de los ensayos clínicos controlados patrocinados: El gasto evitable en medicamentos para el tratamiento de la artritis reumatoidea

    Dec 1, 2019, 00:00

  • Health Economics and Outcomes Research Knowledge Needs Assessment for Latin America [Editor's Choice]

    Dec 1, 2019, 00:00

  • Budget Impact of Cryoablation Versus Radiofrequency Ablation of Atrial Fibrillation in the Brazilian Public Healthcare System

    Dec 1, 2019, 00:00

  • The Cost-Effectiveness of Continuous Versus Intermittent Renal Replacement Therapies in Acute Kidney Injury: Perspective of the Social Services for the Elderly in Argentina

    Dec 1, 2019, 00:00

  • New Challenges in Oncology for the Brazilian Private Health Sector: Specialists' Concerns After the ISPOR International Congress in Boston, Massachusetts, 2017

    Dec 1, 2019, 00:00

  • Epidemiología, consumo de recursos y costos del manejo médico de la Hepatitis C en Argentina, Colombia, Uruguay y Venezuela

    Dec 1, 2019, 00:00

  • EP4 HOW IS SELF-PERCEIVED HEALTH STATUS (EQ-5D) ASSOCIATED WITH SOCIOECONOMIC CONDITIONS IN 22 LATIN AMERICAN COUNTRIES?

    Oct 1, 2019, 00:00

  • PMD8 COST-EFFECTIVENESS OF THERMOABLATION VERSUS SURGERY FOR TREATMENT OF LIVER METASTASIS

    Oct 1, 2019, 00:00

  • PCN29 TENDENCIAS EN LA MORTALIDAD DEL CANCER DE MAMA EN COLOMBIA EN MUJERES MAYORES DE 60 AÑOS

    Oct 1, 2019, 00:00

  • PDG9 EVALUACIÓN PARA LA SELECCIÓN DE PRECIO MÁXIMO DE VENTA DE MEDICAMENTOS

    Oct 1, 2019, 00:00

  • PIT7 THE PROFILE OF FIREARMS INJURIES IN BRAZIL BETWEEN 2009 AND 2016

    Oct 1, 2019, 00:00

  • PRS9 ESTIMATIVA DO CUSTO DA ASMA EM UM PLANO DE SAUDE NO BRASIL - ESTUDO DE MUNDO REAL

    Oct 1, 2019, 00:00

  • PIH15 CURRENT PANORAMA OF THE SURGICAL TREATMENT OF ENDOMETRIOSIS BY THE BRAZILIAN PUBLIC SYSTEM

    Oct 1, 2019, 00:00

  • PNS31 A VIA ADMINISTRATIVA COMO UMA ALTERNATIVA DE ACESSO AO MEDICAMENTO NO SISTEMA ÚNICO DE SAÚDE: SOLUÇÃO OU PROBLEMA?

    Oct 1, 2019, 00:00

  • PMD3 ANALISIS DE IMPACTO PRESUPUESTARIO SOBRE LA INCORPORACION DEL COCIENTE SFLT-1/PLGF PARA PREDECIR EL RIESGO DE PREECLAMPSIA EN EL SANATORIO FINOCHIETTO DE ARGENTINA

    Oct 1, 2019, 00:00

  • PSU5 ANALISIS COSTE CONSECUENCIA DEL TRASPLANTE DE PROGENITORES HEMATOPOYETICOS DE DONANTE NO RELACIONADO FINANCIADO POR EL FONDO INTANGIBLE SOLIDARIO DE SALUD DEL PERU

    Oct 1, 2019, 00:00

  • PIN15 PUBLIC HEALTH IMPACT OF DENGUE VACCINATION WITH SCREENING IN BRAZIL

    Oct 1, 2019, 00:00

  • MT3 ICD THERAPY FOR SUDDEN CARDIAC ARREST PREVENTION IS POTENTIALLY COST-EFFECTIVE IN THE 1.5 PRIMARY PREVENTION POPULATION IN COLOMBIA: AN ECONOMIC EVALUATION OF THE IMPROVED SCA STUDY

    Oct 1, 2019, 00:00

  • PDB7 COST COMPARISON OF BOVINE PERICARDIUM (BP) VS. BIOCOMPATIBLE GLYCOLIDE COPOLYMER BUTTRESS IN GASTRIC STAPLE LINE REINFORCEMENT (SLR)

    Oct 1, 2019, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7 (current)
  • 8
  • 9
  • 10
  • »